Meetings
The Society for Experimental Biology and Medicine holds an annual member's meeting in conjunction
with the EB meetings each year.
SEBM Symposium
Experimental Biology 2011
Sunday, April 10th
8:00-10:00 AM
Washington, DC Conference Center, Room 146A
Energy Metabolism and the Pathogenesis, Treatment and Prevention of Obesity and Diabetes
The United States is suffering from a pandemic of metabolic diseases, in which more than 30% of adults are obese, more than 80 million have some form of cardiovascular disease, and approximately 24 million have type 2 diabetes. The purpose of this symposium is to provide a forum for presentation, discussion and integration of the latest concepts and breakthroughs in our understanding of the regulation of metabolism as it relates to the pathogenesis and therapies for successful treatment and prevention of metabolic syndrome, obesity and diabetes. To achieve this goal four imminent speakers will present their research and perspectives. Dr. Newgard will discuss comprehensive metabolic profiling, or "metabolomics". This is emerging as a valuable tool for defining the full range of metabolic disturbances that accompany these chronic diseases, leading to novel and testable hypotheses about disease mechanisms. Progress in these areas will be reviewed in this lecture. Dr. Goodyear will focus on our expanding knowledge of the role of AMP-activated protein kinase (AMPK) in skeletal muscle energy metabolism. In addition, emerging data suggesting that AMPK related kinases are also critical in metabolism will be discussed. Dr. Franco Folli will discuss his findings in human diabetics, which are at the interface of basic and clinical research. These studies provide basic science mechanisms into the pathogenesis of human obesity and type 2 diabetes and a basis for the development of practical therapies. Dr. Kendall will provide important public health insights into metabolism and the global diabetes and obesity pandemic, and breakthroughs in diabetes treatment and prevention.
| Chairs: | Martin L. Adamo, PhD, University of Texas Health Science Center at San Antonio |
| David M. Kendall, MD, American Diabetes Association |
| 8:00 AM | Changes in Fuel Selection in Chronic Metabolic Diseases Revealed by Comprehensive Metabolic Profiling Christopher B. Newgard, PhD, Duke University Medical Center |
| 8:30 AM | AMPK and AMPK Related Kinases: Critical Regulators of Energy Metabolism Laurie Goodyear, PhD, Joslin Diabetes Center |
| 9:00 AM | Pathophysiology of Type 2 Diabetes: Implications for Therapy Franco Folli, MD, PhD, University of Texas Health Science Center at San Antonio |
| 9:30 AM | Diabetes Care 2020 – From Scientific Discovery to Clinical Translation David M. Kendall, MD, American Diabetes Association |
SEBM Symposium at EB 2010
Evolving from Reductionism to Holism: The Future is Systems Medicine
Chairs: Susan E. Mulroney, Georgetown University and Howard Federoff, Georgetown University
"Systems Medicine and the Emergence of Proative Medicine - Predictive, Personalized, Preventive and Participatory"
Lee Hood, MD, PhD, Institute for Systems Biology
"A Systems Medicine Approach for Neurological Diseases"
Howard Federoff, MD, PhD, Georgetown University Medical Center
"A Systems Medicine Approach to Treating Cancer"
Michael Cusick, PhD, Dana Farber Cancer Institute, Havard University
"Why Should We Train Clinicians in Systems Biology"?
Robert Clarke, PhD, Georgetown University
"Legan, Ethical and Policy Implications of Systems Medicine"
Elenora E. Connors, JD, MPH, O'Neill Institute for National and Global Health Law, Georgetown University Law School
SEBM Symposium at EB 2009
The Co-morbidity of Stress and Disease: Effects of Chronic Stress on Metabolism, Cardiovascular Disease and Behavior
Chairs: Susan E. Mulroney, Georgetown University and Yvette Tache, UCLA
"Corticotropin-Releasing Hormone and Stress-Related Disease"
Yvette Tache, PhD, David Geffen School of Medicine, UCLA
"Chronic stress exacerbates development of metabolic syndrome via an NPY-mediated mechanism"
Zofia Zukowska, MD, PhD, Georgetown University Medical Center
"Stress and anxiety"
Annika Thorsell, PhD, Staff Scientist, NIH/NIAA
"Adaptation to Extreme Stress: Neuropeptide Y, PTSD, and Long-term Health Consequences"
Ann Rasmusson, MD, Yale University and VA National Center for PTSD
SEBM Symposium at EB 2008, San Diego, California
"Progress in Pharmacogenomics and Its Promise for Medicine"
Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina
"Implications of Pharmocogenomics for Drug Development"
Randal J. Kirk, J.D., CEO, Third Security, LLC
"Implications of pharmacogenomics requiring regulatory agency"
Mary K. Pendergast, J.D., L.L.M, Pendergast Consulting, Washington, DC
"Applications of pharmacogenomics in the use of psychotropic drugs"
Meeta Patnaik, M.D., Senior Vice President, Predictive Diagnostics Development for PGxHealth
"Pharmaco-proteomic approaches to understanding the mechanisms and side effects of sickle cell drug therapy"
Steven R. Goodman, PhD, Editor-in-Chief, Experimental Biology and Medicine, University of Texas at Dallas
SEBM Symposium at EB 2007, Washington D.C.
"Nanotechnology, Biology, and Medicine in SEBM's Second Century"
SEBM gratefully acknowledges Genentech for their donation in support of this symposium.
Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina
"Engineered viruses for biomedical science"
M.G. Finn, The Scripps Research Institute
"Biological structures of mesosclae systems"
Stephen G. Sligar, University of Illinois
Experimental biology and medicine" in SEBM's second century
Steven R. Goodman, University of Texas at Dallas
SEBM Symposium at EB 2006, San Francisco
"The Role of Modern Biology and Medicine in Drug Development in Academia and Industry"
Chairpersons: Charles A.Blake, University of South Carollina and Kenneth L. Barker, State University of New York, Syracuse
Ted W. Love, Nuvelo, Inc.
"How to Attract the Best and Brightest to Benefit Drug Development"
Timothy P. Clackson, ARIAD Pharmaceuticals, Inc
"Translational Research In Academia and Industry"
Scott P. Kennedy, Pfizer Gobal R&D
"Effective Partnering of Academic and Physician Scientistswith the Pharmaceutical Drug Development Industry"
Discussion Leader: Burton E. Sobel, University of Vermont
SEBM Symposium at EB 2005, San Diego
"Physiological Proteomics"
Chairpersons: Charles A. Blake and Steven R. Goodman
Charles A. Blake, University of South Carolina
"The proteomics of the anterior pituitary gland"
Steven R. Goodman, University of of Texas at Dallas
"The proteomics of sickle cell disease"
Carlos Gusti Gartner, Harvard Medical School
"Catch-and-release (CAR) reagents: new tools for broadscale analysis of the proteome"
Mark W. Duncan, Univeristy of Colorado Health Sciences Center
"Clinical applications of proteomics"
SEBM Symposium at EB 2004, Washington, DC
Support for this symposium has been provided by AstraZeneca
"Non-hemostatic Physiological Effects of Hemostatis-related Components"
Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York
David J. Loskutoff, Scripps Research Institute
"Role of PAI-1 in Cell Adhesion and Detachment"
Daniel A. Lawrence, American Red Cross Holland Laboratories
"Fibrinolytic Molecules and Neural Function"
Jay L. Degen, Children's Hospital Research Foundation, Cincinnati
"Dissociation of the Hemostatic and Inflammatory Roles of Fibrinogen"
Jerry Ware, Scripps Clinic
"Septins in Platelets and Neural Tissue"
SEBM Symposium at EB 2003, San Diego
Support for this symposium has been provided by Merck & Co and AstraZeneca.
"Career Planning for Experimental Biology, Biomedical and Physician Scientists"
Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York
"Physician-Scientists: Preparation, Opportunities, and National Need"
Kenneth Kaushansky, MD, University of California at San Diego
Biological Scientists in Industry: What Companies Need and Their Criteria for Selection of Professional Scientific Staff"
William T. Schrader, PhD, Schrader Biotech Consulting, Inc
"Building and Supporting Effective Academic Clinical Research Programs in Today's Market-driven Health Care Environment"
Kenneth L. Barker, PhD, Upstate Medical University, New York
"Balancing the Competing Career Demands of the Academic Physician-Scientist: Personal Challenges and Rewards"
Mary Sue O'Dorisio, MD, PhD, University of Iowa
CHAPTER MEETINGS
SEBM regional chapters conduct annual meetings with invited speakers and graduate student abstract presentations.
For additional information, please contact the chapter.
 |
 |